Glafabra Therapeutics, Inc. logo

Glafabra Therapeutics, Inc. Newsroom

Visit Website →

Primary Contact

Chris Hopkins

Press Releases

Glafabra Therapeutics enters into an LOI agreement with the University of Utah to collaborate with the Utah Data Coordinating Center and The Cell Therapy and Regenerative Medicine Program. Clinical trials are being planned to test a novel LV gene therapy as a treatment option for patients with Fabry Disease.

Contact: Chris Hopkins[email protected]8016319114

The licensed technology improves the potency of cell gene therapies by increasing the transformation capacity of lentivirus vectors. Dramatic improvements in patient outcomes are expected from the resulting higher expression of therapeutic protein.

Contact: Chris Hopkins[email protected]8016319114

Showing 1-2 of 2 releases